Clinical trial
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
NCT00192660 · Kirby Institute, Other · Completed
Key facts
| NCT number | NCT00192660 |
|---|---|
| Title | HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) |
| Official title | Analysis of Lipodystrophy in HIV-Infected Individuals A Prospective, Non-randomised, 48 Week Study of the Effect of PI Containing and Non-PI Containing Antiretroviral Regimens on the Expression of Adipocyte Specific Genes, Protein Levels and Cellular Structure in HIV-infected Individuals, Naive to… |
| Lead sponsor | Kirby Institute, Other |
| Collaborators | St Vincent's Hospital, Sydney National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV-Associated Lipodystrophy Syndrome, Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | Lamivudine, Stavudine, Didanosine, Zidovudine, Tenofovir, Abacavir, Efavirenz (EFV), Nevirapine, Indinavir, Saquinavir and 5 more |
| Enrollment | 80 |
| Start date | Feb 1, 2003 |
| Primary completion | Oct 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Apr 12, 2012 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: